Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier‐Luc Clermont, Cheryl D. Helgason, Jiarui Ding et al.|Clinical Epigenetics|2016Cited by 78
Ruscogenin attenuates particulate matter-induced acute lung injury in mice via protecting pulmonary endothelial barrier and inhibiting TLR4 signaling pathwayYuwei Wang, Yuanyuan Zhang|Acta Pharmacologica Sinica|2020Cited by 41
METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial–mesenchymal transitionYuwei Wang, Xiaodong Sun|Journal of Molecular Cell Biology|2023Cited by 33
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological TumorsHaiting Duan, Jinxin Che, Jingyu Zhang et al.|Journal of Medicinal Chemistry|2024Cited by 19
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemiaJingyu Zhang, Jinxin Che, Haiting Duan et al.|European Journal of Medicinal Chemistry|2023Cited by 14